Back to top of page

HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)

To apply for this grant, the following information is required:

​

1. Project Title: Provide a title for your research project.

2. Abstract: Write a summary of your proposed research project.

3. Introduction: Describe the background and rationale for developing non-addictive analgesic therapeutics for pain treatment.

4. Objectives: Clearly state the specific objectives of your research project.

5. Research Plan: Provide a detailed plan for developing assays, screening, and early optimization work to develop a non-addictive therapeutic for pain treatment. Include information on discovery and validation of pharmacodynamic markers efficacy and pharmacokinetic/pharmacodynamic (PK/PD) studies.

6. Relationship to RFA-NS-21-010: Explain how your project aligns with the entry criteria for the RFA-NS-21-010 HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain.

7. Scientific Rationale: Present a rigorous biological rationale for the development of analgesics and scientifically sound assays. If data linking the therapeutic target(s) to the proposed pain indication is not available, provide a plan for developing this data.

8. Pain Conditions: Specify the pain conditions your project aims to address, such as acute pain, chronic pain, neuropathy, musculoskeletal pain, headache disorders, etc.

9. Team Members: Provide a list of the team members involved in the research project, including their qualifications and roles.

10. Budget: Outline the budget for your research project, including details on how the grant funds will be utilized.

11. Timeline: Present a timeline for the completion of different project milestones within the 5-year award period.

12. Expected Outcomes: Describe the expected outcomes of your research project and how it will contribute to the development of non-addictive analgesic therapeutics.

13. References: Include a list of references cited in the proposal.

14. Additional Supporting Documents: Any additional documents required for the application, such as CVs of team members, letters of collaboration, etc.

​

It is important to thoroughly review the specific requirements and guidelines provided by the funding organization.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows